The Operating System for Bio Investment Teams
Turn days of research into hours. Maven Bio accelerates screening, deep dives, and thesis iteration.
Strategic AdvantagesAccelerate decisions. Align teams. Build lasting advantage.
Investment timelines are compressed. Maven Bio accelerates the research phase so your team qualifies opportunities and builds conviction before the window closes.
BenefitsTurn days of research into hours. Maven Bio accelerates screening, deep dives, and thesis iteration.
Screen across hundreds of assets, compare competitive dynamics at depth, surface patterns in clinical data. Maven Bio lets you run diligence that wasn't practical before.
Encode your investment criteria so every analyst evaluates opportunities the same way. Consistent frameworks mean cleaner IC discussions and process that scales.
Every insight traces to primary sources—protocols, filings, clinical data. Build conviction on evidence, not narratives, and answer hard questions with analysis others can verify.
Investment TeamsFrom early-stage sourcing to public market coverage, Maven Bio supports the diligence, monitoring, and thesis-building your team runs daily.
Identify emerging assets early, run differentiated diligence on competitive rounds, and track portfolio companies with structured alerts.
Evaluate platforms and bolt-ons with full pipeline, market, and competitive context—grounded in primary sources, not broker summaries.
Produce deeper buy-side and sell-side materials, respond to pitches with sourced analysis, and support live deals with evidence-backed answers.
Cover more names with less manual work, monitor trial and regulatory catalysts across positions, and pressure-test theses against competitive dynamics.
Higher-Value WorkMaven Bio helps teams move faster, go deeper, and act with more conviction.
Maven Bio takes on the manual work—screening assets, pulling trial data, monitoring portfolios. Your team gets analysis ready to pressure-test, not raw data to wade through.
